Bone Cancer
37
3
8
15
Key Insights
Highlights
Success Rate
63% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
24.3%
9 terminated out of 37 trials
62.5%
-24.0% vs benchmark
3%
1 trials in Phase 3/4
53%
8 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (37)
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases
Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in Osteosarcoma
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone
Enhanced Assistance During Radiotherapy for Unmet Essential Needs
Pediatric Oncological Orthopaedic Reconstruction
Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Osteosarcoma Maintenance Therapy With OST31-164
The Registry of Oncology Outcomes Associated with Testing and Treatment
9-ING-41 in Patients with Advanced Cancers
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
Vaccine Therapy in Treating Patients With Metastatic Cancer
Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis
18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment
Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
Insights Into Participating in Studies for Bone Cancer
A Dose Finding Study to Treat Bone Tumor(s)
Functional Outcomes of Knee Protheses for Malignant Tumours of Bone